
A Medicare program launching next month will offer weight-loss drugs like Wegovy and Zepbound for $50 a month. The rollout could become one of the largest ever, straining doctors' offices as seniors seek GLP-1 prescriptions. Clinicians worry patient counseling on dosages and side effects will suffer.
Tap to vote and see what everyone thinks.
Summary by ByteBrief